FitLife Brands (FTLF) Competitors $17.64 -0.49 (-2.70%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$17.65 +0.01 (+0.06%) As of 09/12/2025 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FTLF vs. IMTX, RZLT, GHRS, RLAY, MAZE, NRIX, TBPH, KURA, BCAX, and SVRAShould you be buying FitLife Brands stock or one of its competitors? The main competitors of FitLife Brands include Immatics (IMTX), Rezolute (RZLT), GH Research (GHRS), Relay Therapeutics (RLAY), Maze Therapeutics (MAZE), Nurix Therapeutics (NRIX), Theravance Biopharma (TBPH), Kura Oncology (KURA), Bicara Therapeutics (BCAX), and Savara (SVRA). These companies are all part of the "pharmaceutical products" industry. FitLife Brands vs. Its Competitors Immatics Rezolute GH Research Relay Therapeutics Maze Therapeutics Nurix Therapeutics Theravance Biopharma Kura Oncology Bicara Therapeutics Savara Immatics (NASDAQ:IMTX) and FitLife Brands (NASDAQ:FTLF) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, media sentiment, risk, profitability, dividends and analyst recommendations. Does the media refer more to IMTX or FTLF? In the previous week, Immatics had 1 more articles in the media than FitLife Brands. MarketBeat recorded 6 mentions for Immatics and 5 mentions for FitLife Brands. FitLife Brands' average media sentiment score of 1.23 beat Immatics' score of 1.03 indicating that FitLife Brands is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Immatics 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive FitLife Brands 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has better earnings & valuation, IMTX or FTLF? Immatics has higher revenue and earnings than FitLife Brands. Immatics is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioImmatics$168.65M4.19$16.47M-$0.65-8.95FitLife Brands$64.47M2.57$8.98M$0.8421.00 Which has more volatility and risk, IMTX or FTLF? Immatics has a beta of 1.02, indicating that its share price is 2% more volatile than the S&P 500. Comparatively, FitLife Brands has a beta of 0.65, indicating that its share price is 35% less volatile than the S&P 500. Do institutionals & insiders have more ownership in IMTX or FTLF? 64.4% of Immatics shares are owned by institutional investors. Comparatively, 2.3% of FitLife Brands shares are owned by institutional investors. 3.3% of Immatics shares are owned by insiders. Comparatively, 61.4% of FitLife Brands shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is IMTX or FTLF more profitable? FitLife Brands has a net margin of 12.63% compared to Immatics' net margin of -59.29%. FitLife Brands' return on equity of 21.70% beat Immatics' return on equity.Company Net Margins Return on Equity Return on Assets Immatics-59.29% -15.60% -12.31% FitLife Brands 12.63%21.70%13.45% Do analysts recommend IMTX or FTLF? Immatics currently has a consensus target price of $14.67, suggesting a potential upside of 152.00%. FitLife Brands has a consensus target price of $23.00, suggesting a potential upside of 30.39%. Given Immatics' stronger consensus rating and higher possible upside, analysts clearly believe Immatics is more favorable than FitLife Brands.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Immatics 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.83FitLife Brands 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 SummaryImmatics beats FitLife Brands on 10 of the 17 factors compared between the two stocks. Get FitLife Brands News Delivered to You Automatically Sign up to receive the latest news and ratings for FTLF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FTLF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FTLF vs. The Competition Export to ExcelMetricFitLife BrandsMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$170.26M$10.93B$5.86B$10.14BDividend YieldN/A1.83%5.68%4.59%P/E Ratio21.0021.1374.5225.93Price / Sales2.5730.79547.62126.81Price / Cash17.9024.8137.5660.44Price / Book4.493.5212.166.29Net Income$8.98M$210.50M$3.28B$270.77M7 Day Performance-5.82%-0.18%0.87%3.88%1 Month Performance8.75%1.09%4.96%4.88%1 Year Performance6.75%-10.96%60.75%26.01% FitLife Brands Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FTLFFitLife Brands4.3359 of 5 stars$17.64-2.7%$23.00+30.4%+5.0%$170.26M$64.47M21.0020Positive NewsIMTXImmatics2.9126 of 5 stars$5.79-0.3%$14.67+153.3%-53.3%$703.77M$168.65M-8.91260Positive NewsRZLTRezolute2.7547 of 5 stars$8.08+1.6%$12.50+54.7%+47.3%$702.96MN/A-7.0340News CoverageUpcoming EarningsGHRSGH Research2.5317 of 5 stars$13.42-0.7%$32.00+138.5%+41.1%$698.03MN/A-18.1310Positive NewsRLAYRelay Therapeutics2.908 of 5 stars$4.06-0.1%$17.50+331.6%-47.6%$697.40M$10.01M-2.07330MAZEMaze TherapeuticsN/A$15.84+5.8%$26.33+66.2%N/A$694.58M$167.50M0.00121Trending NewsAnalyst ForecastNRIXNurix Therapeutics2.3805 of 5 stars$8.98-7.5%$29.07+223.9%-61.6%$689.89M$54.55M-3.46300News CoveragePositive NewsGap DownTBPHTheravance Biopharma3.4744 of 5 stars$13.69-1.7%$21.33+55.8%+76.3%$689.68M$64.38M57.06110News CoveragePositive NewsAnalyst ForecastShort Interest ↑Gap UpKURAKura Oncology4.3171 of 5 stars$7.92-2.7%$24.10+204.4%-58.8%$687.89M$53.88M-3.51130Positive NewsInsider TradeBCAXBicara Therapeutics1.9928 of 5 stars$12.45+1.3%$32.25+159.1%N/A$679.82MN/A-3.9332SVRASavara3.2223 of 5 stars$3.82-0.9%$7.50+96.6%-16.0%$659.39MN/A-7.6320Analyst ForecastGap Up Related Companies and Tools Related Companies Immatics Competitors Rezolute Competitors GH Research Competitors Relay Therapeutics Competitors Maze Therapeutics Competitors Nurix Therapeutics Competitors Theravance Biopharma Competitors Kura Oncology Competitors Bicara Therapeutics Competitors Savara Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FTLF) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FitLife Brands Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FitLife Brands With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FTLF Stock Alerts